Want to join the conversation?
$VRTX 2Q15 Call: During the quarter, Vertex achieved reimbursement approval for non-G551D gating mutations in several European countries where these mutations are prevalent, including Italy, France, England and the Netherlands. Today, more than 85% of eligible gating patients in Europe now have access to KALYDECO.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.